In our center, one case of PAP without hypercholesterolemia experienced improvements in dyspnea, radiographic abnormalities, and pulmonary function after 18 months of oral statin treatment which already responded poorly to WLL and inhaled GM-CSF supplementation [14]. This evidence concerns the gene CSF2 and familial hypercholesterolemia.